Financial Snapshot

Revenue
$12.71M
TTM
Gross Margin
34.54%
TTM
Net Earnings
-$10.58M
TTM
Current Assets
Q2 2024
Current Liabilities
Q2 2024
Current Ratio
2.88%
Q2 2024
Total Assets
Q2 2024
Total Liabilities
Q2 2024
Book Value
-$142.7M
Q2 2024
Cash
Q2 2024
P/E
-0.1739
Nov 11, 2024 EST
Free Cash Flow
$1.888M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue $13.62M $52.58M $72.09M $66.35M $73.46M $73.29M $85.50M $86.32M $81.67M $61.43M $76.23M
YoY Change -74.1% -27.06% 8.65% -9.68% 0.23% -14.28% -0.95% 5.69% 32.96% -19.42%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Selling, General & Admin $6.401M $15.98M $13.15M $16.29M $25.55M $27.08M $29.03M $33.45M $25.52M $22.24M $23.39M
YoY Change -59.93% 21.46% -19.25% -36.24% -5.66% -6.73% -13.21% 31.08% 14.78% -4.94%
% of Gross Profit 127.71% 111.37% 79.33% 149.71% 228.39% 206.9% 152.7% 158.59% 220.22% 220.52% 99.19%
Research & Development $1.000K $35.00K $436.0K $1.377M $1.226M $1.577M $1.559M $1.395M
YoY Change -97.14% -91.97% -68.34% 12.32% -22.26% 1.15% 11.76%
% of Gross Profit 0.01% 0.31% 3.33% 7.24% 5.81% 13.61% 15.46% 5.92%
Depreciation & Amortization $35.00K $52.00K $80.00K $27.00K $1.713M $2.575M $3.170M $3.008M $1.480M $1.425M $1.624M
YoY Change -32.69% -35.0% 196.3% -98.42% -33.48% -18.77% 5.39% 103.24% 3.86% -12.25%
% of Gross Profit 0.7% 0.36% 0.48% 0.25% 15.32% 19.68% 16.67% 14.26% 12.77% 14.13% 6.89%
Operating Expenses $6.401M $15.98M $13.15M $16.29M $25.58M $27.08M $40.14M $34.68M $27.10M $23.79M $24.79M
YoY Change -59.93% 21.46% -19.25% -36.33% -5.53% -32.54% 15.74% 27.97% 13.89% -4.0%
Operating Profit -$1.389M -$1.971M -$7.692M -$5.408M -$38.77M -$13.99M -$21.13M -$12.36M -$13.93M -$12.15M $192.0K
YoY Change -29.53% -74.38% 42.23% -86.05% 177.11% -33.78% 70.93% -11.29% 14.65% -6429.17%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Interest Expense $8.271M $7.902M $8.611M $8.954M $9.876M $9.704M $8.934M $8.848M $7.001M $6.388M $5.547M
YoY Change 4.67% -8.23% -3.83% -9.34% 1.77% 8.62% 0.97% 26.38% 9.6% 15.16%
% of Operating Profit 2889.06%
Other Income/Expense, Net -$8.230M -$6.226M $1.376M -$8.943M -$5.655M -$6.390M -$9.309M $12.63M -$22.46M -$8.917M -$2.641M
YoY Change 32.19% -552.47% -115.39% 58.14% -11.5% -31.36% -173.68% -156.24% 151.92% 237.64%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Pretax Income -$9.619M -$8.197M -$14.93M -$14.35M -$44.42M -$20.38M -$30.43M $275.0K -$36.40M -$21.07M -$2.449M
YoY Change 17.35% -45.09% 4.01% -67.69% 117.97% -33.04% -11166.91% -100.76% 72.75% 760.31%
Income Tax $43.00K $25.00K $13.00K $38.00K $79.00K $29.00K -$943.0K $959.0K $14.00K $61.00K $33.00K
% Of Pretax Income 348.73%
Net Earnings -$13.71M -$8.222M -$14.94M -$14.39M -$44.50M -$20.41M -$29.49M -$684.0K -$36.41M -$21.13M -$2.482M
YoY Change 66.8% -44.97% 3.83% -67.67% 118.05% -30.8% 4211.55% -98.12% 72.31% 751.33%
Net Earnings / Revenue -100.71% -15.64% -20.72% -21.69% -60.58% -27.85% -34.49% -0.79% -44.58% -34.4% -3.26%
Basic Earnings Per Share -$0.05 -$0.03 -$0.06 -$0.06 -$0.17 -$0.08 -$0.12 $0.00 -$0.15
Diluted Earnings Per Share -$0.05 -$0.03 -$0.06 -$0.06 -$0.18 -$0.09 -$0.12 -$0.09 -$0.15 -$99.03K -$50.00

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Cash & Short-Term Investments $19.00K $868.0K $3.631M $424.0K $270.0K $6.227M $1.350M $5.097M $1.240M $466.0K $0.00
YoY Change -97.81% -76.09% 756.37% 57.04% -95.66% 361.26% -73.51% 311.05% 166.09%
Cash & Equivalents
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $194.0K $758.0K $1.045M $2.195M $3.119M $6.560M $2.256M $2.870M $1.657M $4.421M $0.00
YoY Change -74.41% -27.46% -52.39% -29.62% -52.45% 190.78% -21.39% 73.2% -62.52%
Inventory $3.402M $9.407M $5.814M $6.301M $6.569M $7.945M $17.17M $17.60M $13.73M $18.42M
Prepaid Expenses
Receivables $2.072M $4.105M $6.881M $8.425M $6.342M $8.566M $6.528M $7.768M $7.880M $4.604M
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $5.687M $15.14M $17.37M $17.35M $16.30M $29.30M $27.30M $33.34M $24.50M $28.28M $10.00K
YoY Change -62.43% -12.85% 0.15% 6.41% -44.36% 7.31% -18.1% 36.04% -13.35% 282690.0%
Property, Plant & Equipment $1.898M $4.353M $5.620M $4.775M $72.00K $1.117M $3.169M $3.528M $3.712M $2.680M
YoY Change -56.4% -22.54% 17.7% 6531.94% -93.55% -64.75% -10.18% -4.96% 38.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.290M $1.301M $1.301M $760.0K $834.0K $1.720M $1.762M $1.667M $1.475M $986.0K
YoY Change -0.85% 0.0% 71.18% -8.87% -51.51% -2.38% 5.7% 13.02% 49.59%
Total Long-Term Assets $3.308M $5.774M $7.497M $17.61M $14.09M $41.94M $45.79M $59.49M $61.70M $11.23M $0.00
YoY Change -42.71% -22.98% -57.42% 24.98% -66.41% -8.41% -23.03% -3.58% 449.39%
Total Assets $8.995M $20.91M $24.87M $34.95M $30.39M $71.24M $73.09M $92.83M $86.20M $39.51M $10.00K
YoY Change
Accounts Payable $6.803M $6.621M $6.047M $4.712M $6.313M $8.081M $10.15M $7.866M $16.75M $12.90M $10.00K
YoY Change 2.75% 9.49% 28.33% -25.36% -21.88% -20.35% 28.99% -53.05% 29.87% 128900.0%
Accrued Expenses $43.23M $36.28M $31.15M $26.54M $20.67M $15.82M $10.34M $11.43M $5.312M $2.061M
YoY Change 19.16% 16.49% 17.36% 28.38% 30.64% 53.1% -9.6% 115.25% 157.74%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $93.64M $97.38M $97.41M $96.85M $91.13M $70.54M $68.09M $11.63M $16.56M $13.65M
YoY Change -3.84% -0.03% 0.58% 6.28% 29.19% 3.59% 485.44% -29.78% 21.32%
Total Short-Term Liabilities $145.8M $142.2M $136.8M $132.0M $118.1M $98.80M $95.37M $37.39M $71.72M $29.32M $10.00K
YoY Change 2.56% 3.97% 3.58% 11.75% 19.58% 3.6% 155.08% -47.87% 144.59% 293120.0%
Long-Term Debt $0.00 $0.00 $0.00 $476.0K $0.00 $15.00M $3.383M $50.99M $12.86M $12.77M $10.00K
YoY Change -100.0% -100.0% 343.39% -93.37% 296.45% 0.7% 127620.0%
Other Long-Term Liabilities $2.197M $4.038M $5.197M $4.592M $0.00 $1.324M $1.565M $1.727M $1.890M $2.052M $0.00
YoY Change -45.59% -22.3% 13.18% -100.0% -15.4% -9.38% -8.62% -7.89%
Total Long-Term Liabilities $2.197M $4.038M $5.197M $5.068M $0.00 $16.32M $4.948M $52.72M $14.75M $14.82M $10.00K
YoY Change -45.59% -22.3% 2.55% -100.0% 229.91% -90.61% 257.37% -0.49% 148140.0%
Total Liabilities $148.0M $146.2M $142.0M $137.1M $118.1M $115.1M $100.3M $91.06M $86.47M $44.15M $10.00K
YoY Change 1.23% 3.01% 3.54% 16.04% 2.62% 14.77% 10.16% 5.31% 95.88% 441360.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Basic Shares Outstanding 259.1M shares 259.1M shares 258.8M shares 257.3M shares 255.6M 254.3M 252.9M 261.7M 241.1M
Diluted Shares Outstanding 259.1M shares 259.1M shares 258.8M shares 259.1M shares 265.5M 266.7M 252.9M 273.2M 241.1M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.84 Million

About Twinlab Consolidated Holdings Inc

Twinlab Consolidated Holdings, Inc. engages in the provision of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty stores retailers, on-line retailers and websites. The company is headquartered in Boca Raton, Florida and currently employs 17 full-time employees. The company went IPO on 2014-06-25. Internationally, the Company markets and distributes branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Through NutraScience Labs, it also provides services between private label distributors and contract manufacturers. Its services business involved the facilitation of manufacture of custom products. Its products include vitamins, minerals, resveratrol, collagen, keratin, skincare and sports nutrition products primarily under the Twinlab, Reserveage and ResVitale brands. The company also markets and sells diet and energy products under the Metabolife brand and a full line of herbal teas under the Alvita brand.

Industry: Medicinal Chemicals & Botanical Products Peers: Fuss Brands Corp Safety Shot, Inc. MAKINGORG, INC. Estee Lauder Companies Inc High Sierra Technologies, Inc. Zivo Bioscience, Inc. LifeVantage Corp Mannatech Inc Natural Alternatives International Inc